Ciprofloxacin Lactate intravenous infusion/injection 100ml:200mg

Detailed Product Description

Name: Ciprofloxacin Lactate Injection(100ml:200mg)
Structural formula: C17H18FN3O3. C3H3O3
Mol wt: 421.43
Description the product is colorless or almost colorless pellucid liquid.
Pharmacology and toxicity
Broad spectrum aerobicidal quinolone antibiotic. In vitro ciprofloxacin lactate can resist all of the G- Bacteria effectively. It also has effect on the resistance of G+ Bacteria. But it has lower sensibility for the anaerobic bacteria. As a kind of bactericidal agent, ciprofloxacin can inhibit DNA screw enzyme, preventing them from the metabolism, and lead to bacteria dead.
Pharmacokinetics
After administering by intravenous drip 0.2g or 0.4g, the plasma peak concentration (Cmax) is 2.1μg/ml and 4.6μg/ml respectively. The medicine distributes widely to all kinds of tissues and body liquids(including cerebrospinal fluid) , the concentration in the tissues usually exceed the concentration in the plasma. The binding rate with protein is about 20%~40%. 50%~70% of Ciprofloxacin Lactate is excreted, about 15% of the medicine is excreted as metabolism and a large amount of the medicine is excreted in bile and dejection.
Disease treated
Used for the treatment of :
1.Urinary tract infections
2.Respiratory tract infections
3.Gastrointestinal infections
4.Typhia
5.Bone & joint infections
6.Skin & soft Tissue infections
7.General infection including blood poisoning
Administration and dosage By drip phleboclysis. Dose for the adult is 0.2g every day, with interval 12hours, administration time not less than 30minutes. For the acute infection and infection caused by some bacteria, the dose can be increased to 0.8g/day, two times every day.
the course of treatment:
1.Urinary tract infections: for general urinary tract infection , 5~7days;for complicated urinary tract infection, 7~14days.
2.Pneumonia, skin & Soft Tissue infections: 7~14days.
3.Gastrointestinal infections: 5~7days.
4.Bone & joint infections: 4~6weeks or more time.
5.Typhia: 10~14 days
Side-effect
1.Gastrointestinal reaction: including diarrhea stomach pain or cramps, dysentery, nausea, and vomiting.
2.Centre nerve system reaction: including dizzy, headache, drowsiness, and sleepless.
3.Allergic reaction including tetter, skin pruritus; photosensitivity reaction on few patients
4.The following system may happen on patients occasionally, include;
(1) falling sickness, insanity , restlessness, confusion, delusions and tremors
(2) blood in urine, fever, skin rash
(3) phlebitis
(4) crystalluria, the symptom happen when used with large dose.
(5) arthralgia
5. During the course of treatment few patients may have the following symptoms such as blood serum aminopherase increase, blood urea mitrogen increase, and white cell in the blood picture decrease. But the symptoms are low-grade and temporary.
Contraindication
Forbid to use the medicine for the patients allergic to this medicine and other quinolone drugs.
Attention
1. At present drug resistance of coliform is usual for quinolone drug. Urine breeding sample should be kept before the administration and adjust the administration according to sensitivity test result to the medicine.
2. Administering with high dose or PH of urine>7 may lead to crystalluria. To avoid this, suggest the patients drinking a lot of water and assuring to excrete the urine 1200ml during 24hours.
3.For the patients with renal failure, adjust the administration dose according to the renal function.
4.Moderate to heavy photosensitivity reaction may happen when using the quinolone drugs. So avoid unnecessary or prolonged exposure to sunlight. Stop using the medicine if the aforementioned symptom happens.
5.Hypohepatia may lead to the medicine elimination decreased and concentration of medicine in the plasma increased, especially for the patients with the renal and liver failure. So when using for the patients with the liver and kidney diseases, the abovementioned factors must be taken into account and the dose should be adjusted.
6.Avoid using the medicine for the patients with the disease of central nerve system such as epilepsy or history of epilepsy. If the indicatioe exist, make decision whether or not use after a good thought.
Indication for women in pregnant and suckle
Test on animal do not confirm that the quinolone drug can lead to malformation, but study of administration for the pregnant women have no definite conclusion. Seeing that the medicine may lead to joint affection, thus forbid to use this medicine for the women in pregnant and women in suckle stop sucking when used with this medicine.
Indications for the children
Safety of Ciprofloxacin for the infants and the children younger than 18years old is uncertain. But when used for some kinds of infant animals, the administration may cause joint affection. So the medicine is not available for the infants and the children younger than 18 years old.
Indications for the elder patients
Because this injection partly is excreted via kidney, administer decreased dosage for most of the elder patients with the disease of renal failure.
Substance interactions
1. Urine absifier can decrease the solubility of Ciprofloxacin Lactate in the urine and lead to the crystalluria and renal disease.
2.Administering combined with the hyphylline drug may lead to significantly decreased liver elimination of hyphylline, prolonged T1/2 of blood elimination, and increased drug concentration in the plasma, along with hyphylline intoxication symptoms such as nausea, vomiting, tremors, restlessness, excitement, twitch, heart-throb, and etc. So when using with the hyphylline drug, measure the drug concentration in the plasma and adjust the dosage.
3.When used with Cicrosporin, ciprofloxacin can make the drug concentration in the plasma of the latter increase. During this course, monitor the concentration and adjust the dose.
4.When used with the anticoagulants, ciprofloxacin can increase the effect of the latter. But during this course monitor the prothrombase time.
5.Bednzoic acid can decrease 50% of the secrete of Ciprofloxacin Lactate via renal tubule, so when the above two kinds of medicine are combined for use, toxicity could be produced for the high concentration of ciprofloxacin in the plasma.
6.Ciprofloxacin may interfere the metabolism of the caffeine, which may lead to decreased caffeine elimination, prolonged T1/2 of blood elimination. That may also produce the toxicity for the central nerve system.
Overdose
Pay attention to observe the change of patients condition when acute high dose happens and make expectant and supporting treatment. Remain appropriate amount of fluid infusion. When hemodialysis or peritoneal dialysis are carried out, only little medicine(< 10%) is excreted.
Specifications
100ml: 0.2g
Storage instructions
Light-resistant and store in well-closed containers.
Package
Packed in plastic bottle
Validity Two years

Place of Origin:	Hebei in China
Model No:	100ml:200mg
Brand Name:	SHIMEN
Other Price Terms:	negotiate.
Payment Terms:	L/C,T/T(Bank Transfer),
Minimum Order:	Set/Sets 10000
Supply Ability:	Set/Sets\|400000000\|Year
Package:	plastic bottle infusion
Delivery Time:	35 days